You are here: Industry Insights > Amgen

News List

Amgen, AZ’s asthma drug tezepelumab scores phase III win pharmatimes
November 12, 2020
Amgen and AstraZeneca’s (AZ) experimental asthma drug tezepelumab has scored a phase III win in severe, uncontrolled asthma.
Financial Report: Amgen contractpharma
November 06, 2020
Revenues up 12% in the quarter to $6.4 billion.
Amgen Appoints General Manager, Mainland China as Vice President & General Manager, Japan Asia-Pacific prnasia
November 04, 2020
Amgen Asia Holding Limited has announced the appointment of My Linh Kha as Vice President & General Manager, Japan Asia-Pacific (JAPAC).
Amgen announces NHS collaboration aiming to tackle high cholesterol pharmatimes
October 10, 2020
Amgen has announced a new partnership with two NHS organisations with the aim of tackling the ‘silent killer’ of high cholesterol across the North West Coast of England.
Lilly and Amgen to collaborate for manufacturing COVID-19 antibody therapies expresspharma
September 18, 2020
Together, the companies hope to be able to produce many millions of doses even next year.
Provention Bio Begins Phase 2 Study of Non-responsive Celiac Disease Treatment americanpharmaceuticalreview
September 01, 2020
Provention Bio announced the initiation of the Phase 2b PROACTIVE (PROvention Amgen Celiac ProtecTIVE) study of PRV-015, an anti-interleukin-15 monoclonal antibody, in adult celiac patients not responding to a gluten-free diet, a condition known as ...
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment expresspharma
August 04, 2020
I-SPY COVID will evaluate the impact of cenicriviroc, Otezla, and Firazyr on inflammatory response in severely ill, hospitalised COVID-19 patients.
SomaLogic, Amgen Enter Proteomic Profiling Pact contractpharma
July 31, 2020
Will use SomaLogic’s proteomics technology to help advance Amgen’s drug discovery and development programs.
Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets expresspharma
July 21, 2020
Cipla's cinacalcet hydrochloride tablets, in the strengths of 30mg, 60mg and 90mg, are generic versions of Sensipar, a branded drug marketed by Amgen Inc.
Amgen makes $421m additional investment in BeiGene pharmaceutical-technology
July 15, 2020
Amgen has made an additional investment of approximately $421m to the registered direct offering of ordinary shares of Chinese biotechnology firm BeiGene.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page